Stage IV Prostate Cancer

Oncology·MeSH: Cognitive Dysfunction

Prevalence

256.0 / 100K

Incidence

111.0 / 100K/yr

0 drugs in development·0 companies·7 clinical trials

Frequently asked questions

How many clinical trials target Stage IV Prostate Cancer?

There are 7 clinical trials targeting Stage IV Prostate Cancer tracked by BioSniper.

What is the prevalence of Stage IV Prostate Cancer?

The estimated prevalence of Stage IV Prostate Cancer is approximately 256.0 per 100,000 population.

Deep-dive into Stage IV Prostate Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Stage IV Prostate Cancer — Drugs in Development & Clinical Trials | BioSniper